Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
PHA said the FDA has accepted for filing its sNDA requesting label changes to indicate that Celebrex celecoxib can be safely used over a longer term. The filing is based on 13-month safety data from 8...
